Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Fish and Richardson
Deloitte
Covington
Queensland Health
UBS
Healthtrust
Dow
Novartis

Generated: February 19, 2018

DrugPatentWatch Database Preview

CELEBREX Drug Profile

« Back to Dashboard

Which patents cover Celebrex, and what generic alternatives are available?

Celebrex is a drug marketed by Gd Searle and is included in one NDA.

The generic ingredient in CELEBREX is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Drug patent expirations by year for CELEBREX
Pharmacology for CELEBREX
Medical Subject Heading (MeSH) Categories for CELEBREX

US Patents and Regulatory Information for CELEBREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-002 Dec 31, 1998 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CELEBREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-002 Dec 31, 1998 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-002 Dec 31, 1998 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998 ➤ Sign Up ➤ Sign Up
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for CELEBREX
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Capsules 50 mg ➤ Subscribe 3/21/2008

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Mallinckrodt
US Army
Express Scripts
UBS
Queensland Health
Healthtrust
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot